Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan
· Delayed Price · Currency is TWD 31.85
+0.10 (0.31%)
Apr 29, 2026, 1:30 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 6.06 billion as of April 29, 2026. Its market cap has increased by 7.53% in one year.
Market Cap
6.06B
Enterprise Value
6.84B
Revenue
3.37B
Ranking
n/a
PE Ratio
16.59
Stock Price
31.85
Market Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 6.06B, an increase of 438.28%. That is a compound annual growth rate of 7.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 6.01B |
| Mycenax Biotech | 6.08B |
| AnnJi Pharmaceutical | 5.94B |
| Panion & Bf Biotech | 5.43B |
| Steminent Biotherapeutics | 5.20B |
| UnicoCell Biomed | 5.14B |
| TaiGen Biopharmaceuticals Holdings | 7.19B |
| Acepodia | 7.25B |